pn20
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 16, 2022 (NCT06523088)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Thrombopoietin receptorAGONIST
MPL agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06880081 | Phase 1 | Mar 7, 2025 | Chinese Academy of Medical Sciences, Government of China |
| NCT06521931 | Phase 1 | Dec 6, 2023 | Government of China, Henan Medical University |
| NCT06523088 | Phase 1 | Jun 16, 2022 | Government of China, Soochow University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 3 | 3 | 1 | 2022 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2022 |
4 organizations
Page 1 / 1